IL134505A0 - Coding sequence haplotypes of the human brca2 gene - Google Patents
Coding sequence haplotypes of the human brca2 geneInfo
- Publication number
- IL134505A0 IL134505A0 IL13450598A IL13450598A IL134505A0 IL 134505 A0 IL134505 A0 IL 134505A0 IL 13450598 A IL13450598 A IL 13450598A IL 13450598 A IL13450598 A IL 13450598A IL 134505 A0 IL134505 A0 IL 134505A0
- Authority
- IL
- Israel
- Prior art keywords
- coding sequence
- brca2 gene
- human brca2
- sequence haplotypes
- haplotypes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2539/00—Reactions characterised by analysis of gene expression or genome comparison
- C12Q2539/10—The purpose being sequence identification by analysis of gene expression or genome comparison characterised by
- C12Q2539/105—Involving introns, exons, or splice junctions
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5578497P | 1997-08-15 | 1997-08-15 | |
US6492697P | 1997-11-07 | 1997-11-07 | |
US6536797P | 1997-11-12 | 1997-11-12 | |
US7171598A | 1998-05-01 | 1998-05-01 | |
US8447198A | 1998-05-22 | 1998-05-22 | |
PCT/US1998/016905 WO1999009164A1 (fr) | 1997-08-15 | 1998-08-14 | Haplotypes d'une sequence codante du gene humain brca2 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134505A0 true IL134505A0 (en) | 2001-04-30 |
Family
ID=27535329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13450598A IL134505A0 (en) | 1997-08-15 | 1998-08-14 | Coding sequence haplotypes of the human brca2 gene |
Country Status (5)
Country | Link |
---|---|
EP (3) | EP2275574B1 (fr) |
JP (3) | JP2001514887A (fr) |
AU (1) | AU9292898A (fr) |
IL (1) | IL134505A0 (fr) |
WO (1) | WO1999009164A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6051379A (en) * | 1997-09-23 | 2000-04-18 | Oncormed, Inc. | Cancer susceptibility mutations of BRCA2 |
US7807447B1 (en) | 2000-08-25 | 2010-10-05 | Merck Sharp & Dohme Corp. | Compositions and methods for exon profiling |
US6713257B2 (en) | 2000-08-25 | 2004-03-30 | Rosetta Inpharmatics Llc | Gene discovery using microarrays |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5593840A (en) | 1993-01-27 | 1997-01-14 | Oncor, Inc. | Amplification of nucleic acid sequences |
WO1997019110A1 (fr) * | 1995-11-23 | 1997-05-29 | Cancer Research Campaign Technology Limited | Materiaux et procedes relatifs a l'identification et au sequençagge du gene de susceptibilite brca2 du cancer et ses utilisations |
GB2307477B (en) * | 1995-11-23 | 1997-10-22 | Cancer Res Campaign Tech | Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
IL124620A0 (en) * | 1995-12-18 | 1998-12-06 | Myriad Genetics Inc | Chromosome 13-linked breast cancer susceptibility gene |
US5891857A (en) * | 1996-02-20 | 1999-04-06 | Vanderbilt University | Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
-
1998
- 1998-08-14 EP EP10175317.6A patent/EP2275574B1/fr not_active Expired - Lifetime
- 1998-08-14 AU AU92928/98A patent/AU9292898A/en not_active Abandoned
- 1998-08-14 IL IL13450598A patent/IL134505A0/xx unknown
- 1998-08-14 WO PCT/US1998/016905 patent/WO1999009164A1/fr active Application Filing
- 1998-08-14 EP EP10175418A patent/EP2275575A3/fr not_active Withdrawn
- 1998-08-14 JP JP2000509828A patent/JP2001514887A/ja active Pending
- 1998-08-14 EP EP98945756A patent/EP0994946A1/fr not_active Withdrawn
-
2009
- 2009-03-11 JP JP2009058788A patent/JP2009118863A/ja not_active Withdrawn
-
2013
- 2013-03-26 JP JP2013064698A patent/JP2013143958A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2275574A2 (fr) | 2011-01-19 |
EP2275575A2 (fr) | 2011-01-19 |
EP2275574B1 (fr) | 2015-06-03 |
WO1999009164A1 (fr) | 1999-02-25 |
JP2013143958A (ja) | 2013-07-25 |
WO1999009164A9 (fr) | 1999-05-06 |
JP2009118863A (ja) | 2009-06-04 |
AU9292898A (en) | 1999-03-08 |
JP2001514887A (ja) | 2001-09-18 |
EP2275574A3 (fr) | 2012-06-27 |
EP2275575A3 (fr) | 2012-07-11 |
EP0994946A1 (fr) | 2000-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9622500D0 (en) | Therapeutic gene | |
PL340255A1 (en) | Non-dissolving insulin compositions | |
EP1006186A4 (fr) | Genes humains | |
EP0889055A4 (fr) | Acide hyaluronique oligosulfate | |
EG21712A (en) | Treatment of insulin resistance | |
EP1077996A4 (fr) | GENE EDG3sb HUMAIN | |
GB9700899D0 (en) | Novel treatment | |
SG68001A1 (en) | Silicone rubber composite | |
GB9506470D0 (en) | 5b4t coding scheme | |
GB9700939D0 (en) | Therapy | |
PL340584A1 (en) | Medical spatula | |
IL134505A0 (en) | Coding sequence haplotypes of the human brca2 gene | |
AU132496S (en) | Personal digital assistant | |
AU1541399A (en) | Human nucleotide pyrophosphohydrolase-2 | |
EP0958304A4 (fr) | Sequence nucleotidique codant la proteine de type cd33 | |
AU9321698A (en) | Susceptibility mutation 6495delgc of brca2 | |
AU9034498A (en) | Human nucleotide pyrophosphohydrolase | |
GB0014599D0 (en) | Coding scheme | |
PL336906A1 (en) | Reduction of aromatic halides | |
GB9721692D0 (en) | Novel treatment | |
GB9721693D0 (en) | Novel treatment | |
GB2333527B (en) | Therapeutic gene | |
GB9714742D0 (en) | Medical cement | |
PL318841A1 (en) | Electrolyser | |
HUP9902845A3 (en) | Novel treatment of leptine resistance |